Suppr超能文献

膈肌软组织肉瘤:1972年至1997年间横纹肌肉瘤研究协作组的报告

Soft-tissue sarcomas of the diaphragm: a report from the Intergroup Rhabdomyosarcoma Study Group from 1972 to 1997.

作者信息

Raney R B, Anderson J R, Andrassy R J, Crist W M, Donaldson S S, Maurer H M

机构信息

Department of Clinical Pediatrics, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.

出版信息

J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):510-4. doi: 10.1097/00043426-200011000-00007.

Abstract

PURPOSE

To describe clinical details and outcome of children and adolescents with primary sarcomas of the diaphragm treated on Intergroup Rhabdomyosarcoma Studies (IRS) I through IV.

PATIENTS AND METHODS

We reviewed the records of 15 patients with sarcoma of the diaphragm who were entered on IRS Group protocols between 1972 and 1997. Patient ages at diagnosis ranged from 0.5 to 20 years (median, 13 yrs), and 10 were girls. Patients had chest pain, dyspnea, and/or coughing, decreased breath sounds, and occasionally hepatomegaly.

RESULTS

Localized, gross residual disease after initial surgery was present in 10 patients, and five had metastases at diagnosis (pleura, 3; pericardium, 1; lungs and bones, 1). Tumor subtypes were alveolar rhabdomyosarcoma (RMS) in five cases, embryonal RMS in three, undifferentiated sarcoma in three, extraosseous Ewing sarcoma in three, and unclassified sarcoma in one. Treatment consisted of radiation therapy to the primary tumor and metastases when feasible, and combination chemotherapy with vincristine, actinomycin D, and cyclophosphamide with or without doxorubicin, ifosfamide, cisplatin, and etoposide. Ten patients achieved complete remission (67%), four obtained a partial remission, and one was improved. Five patients (33%) are continuously failure-free and alive at a median of 8.8 years from diagnosis (range, 1.1-15 yrs). However, the other 10 patients experienced relapse at 0.3 to 2 years from start of therapy (median, 1 yr). Sites of relapse were local in five, distant in three, and combined in two. Death after relapse occurred at 0.39 to 2.6 years (median, 1.6 yrs) from diagnosis.

CONCLUSIONS

Sarcomas of the diaphragm are generally deemed unresectable at diagnosis and/or are metastatic. Most of them are not embryonal rhabdomyosarcomas. Treatment with more effective primary chemotherapy to shrink the tumor, followed-up by surgical resection and radiation therapy, should improve the prognosis for patients with sarcomas arising in the diaphragm, especially for the majority who have localized tumors.

摘要

目的

描述在横纹肌肉瘤协作组研究(IRS)I至IV中接受治疗的原发性膈肌肉瘤儿童和青少年的临床细节及预后。

患者与方法

我们回顾了1972年至1997年间纳入IRS组方案的15例膈肌肉瘤患者的记录。诊断时患者年龄为0.5至20岁(中位数为13岁),其中10例为女孩。患者有胸痛、呼吸困难和/或咳嗽、呼吸音减弱,偶尔有肝肿大。

结果

10例患者初始手术后存在局部肉眼残留病灶,5例诊断时有转移(胸膜转移3例;心包转移1例;肺和骨转移1例)。肿瘤亚型包括5例肺泡型横纹肌肉瘤(RMS)、3例胚胎型RMS、3例未分化肉瘤、3例骨外尤文肉瘤和1例未分类肉瘤。治疗包括在可行时对原发性肿瘤和转移灶进行放射治疗,以及联合使用长春新碱、放线菌素D和环磷酰胺进行化疗,可加用或不加用多柔比星、异环磷酰胺、顺铂和依托泊苷。10例患者实现完全缓解(67%),4例部分缓解,1例病情改善。5例患者(33%)持续无瘤生存,自诊断起中位时间为8.8年(范围为1.1至15年)。然而,其他10例患者在治疗开始后0.3至2年复发(中位数为1年)。复发部位5例为局部复发,3例为远处复发,2例为局部和远处联合复发。复发后死亡发生在诊断后0.39至2.6年(中位数为1.6年)。

结论

膈肌肉瘤在诊断时通常被认为无法切除和/或已发生转移。其中大多数不是胚胎型横纹肌肉瘤。采用更有效的原发性化疗缩小肿瘤,随后进行手术切除和放射治疗,应能改善膈肌肉瘤患者的预后,尤其是对大多数局部肿瘤患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验